Brooks Laboratories Limited (NSE:BROOKS)

Brooks Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	10.51	0.43	1.26	0.23	26.05	8.84
Cash & Short-Term Investments	10.51	0.43	1.26	0.23	26.05	8.84
Cash Growth	29.95%	-65.42%	440.95%	-99.11%	194.72%	123.21%
Accounts Receivable	252	199.92	163.16	127.54	176.62	136.98
Other Receivables	7.53	11.4	17.65	3.03	13.69	4.37
Receivables	259.53	211.33	180.84	130.57	190.31	141.35
Inventory	77.42	92.05	96.11	113.03	275.22	236.03
Prepaid Expenses	-	0.83	0.93	0.94	1.77	1.87
Other Current Assets	28.72	34.12	31.36	31.29	118.47	110.74
Total Current Assets	376.17	338.77	310.48	276.06	611.82	498.83
Property, Plant & Equipment	141.97	139.72	136	148.09	1,245	1,077
Long-Term Investments	862.36	735.54	429.13	640.26	2.78	3.28
Other Intangible Assets	-	0.09	0.73	1.99	6.31	6.88
Long-Term Deferred Tax Assets	-	-	-	-	13.55	-
Other Long-Term Assets	18.97	22.82	28.11	29.57	79.75	34.77
Total Assets	1,399	1,237	904.46	1,096	1,959	1,621
Accounts Payable	116.81	136.24	154.43	233.7	280	309.53
Accrued Expenses	12.56	21.96	16.54	23.18	32.34	42.04
Short-Term Debt	-	59	50.42	56.64	110.47	236.37
Current Portion of Long-Term Debt	63.35	0.33	-	-	38.76	33.07
Current Portion of Leases	3.04	2.8	2.43	2.47	1.97	-
Other Current Liabilities	21.11	8.11	6.65	14.23	25.25	15.13
Total Current Liabilities	216.87	228.44	230.48	330.21	488.79	636.14
Long-Term Debt	1.13	1.31	-	-	92.91	144.4
Long-Term Leases	10.81	12.4	3.57	6.02	8.49	-
Pension & Post-Retirement Benefits	-	6.37	6.8	9.03	12.96	10.16
Long-Term Deferred Tax Liabilities	-	-	-	-	-	32.3
Other Long-Term Liabilities	14.02	7.39	7.76	11.17	12.78	6.29
Total Liabilities	242.82	255.9	248.6	356.44	615.92	829.29
Common Stock	294.57	294.57	262.47	247.03	247.03	247.03
Additional Paid-In Capital	-	1,170	777.24	680	860.21	680
Retained Earnings	-	-486.52	-386.85	-190.93	-236.18	-138.49
Comprehensive Income & Other	862.09	2.81	3	3.43	3.84	2.94
Total Common Equity	1,157	981.04	655.85	739.53	874.9	791.48
Minority Interest	-	-	-	-	468.29	-
Shareholders' Equity	1,157	981.04	655.85	739.53	1,343	791.48
Total Liabilities & Equity	1,399	1,237	904.46	1,096	1,959	1,621
Total Debt	78.33	75.83	56.42	65.12	252.59	413.85
Net Cash (Debt)	-67.82	-75.39	-55.16	-64.89	-226.54	-405.01
Net Cash Per Share	-2.39	-2.81	-2.15	-2.63	-9.17	-16.40
Filing Date Shares Outstanding	29.44	29.46	26.25	24.7	24.7	24.7
Total Common Shares Outstanding	29.44	29.46	26.25	24.7	24.7	24.7
Working Capital	159.3	110.33	80.01	-54.15	123.04	-137.31
Book Value Per Share	39.30	33.30	24.99	29.94	35.42	32.04
Tangible Book Value	1,157	980.95	655.12	737.55	868.59	784.6
Tangible Book Value Per Share	39.30	33.30	24.96	29.86	35.16	31.76
Land	-	15.13	15.13	15.13	187.13	187.13
Buildings	-	38.89	38.89	38.45	447.98	442.72
Machinery	-	166.2	160.19	156.49	771.88	697.3
Construction In Progress	-	-	-	-	151.07	6.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.